Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
This is a phase III, multicentre, randomized, double blind, parallel-group, pilot study
designed to compare a long term (12 weeks) versus a short term (2 weeks) treatment with
celecoxib 200 mg/die in treatment and prevention of new flare in patients with osteoarthritis
of the knee.